依功能與用途,為你挑選 12 款 Medd AI 的替代工具。
| 排名 | 工具與標語 | 官方網域 | 每月造訪次數 | 月增幅 | 定價模式 | 主要市場 | 評分 | 比較 |
|---|---|---|---|---|---|---|---|---|
| ● |
| medd.ai |
| 0 |
| 0 (0%) |
| 免費 |
| 全球 |
| — |
| 簡介 |
| 1 | Insight | insightai.dev | 2761 | -78 (-2.7%) | 免費 | 美國 | 4.4 | 比較 |
| 2 | Intelligencia AI | intelligencia.ai | 3872 | -1810 (-31.9%) | 需聯絡報價 | 美國 | 4.1 | 比較 |
| 3 | Dr.Oracle | droracle.ai | 72.38萬 | -8529 (-1.2%) | 免費試用 | 美國 | 4.3 | 比較 |
| 4 | Elicit | elicit.com | 175.15萬 | 5.27萬 (+3.1%) | 免費增值 | 美國 | 4.6 | 比較 |
| 5 | Semantic Scholar | semanticscholar.org | 819.87萬 | 45.07萬 (+5.8%) | 免費 | 美國 | 4.8 | 比較 |
| 6 | Unlearn.AI | unlearn.ai | 1.71萬 | -8233 (-32.5%) | 需聯絡報價 | 美國 | 4.4 | 比較 |
| 7 | Cradle | cradle.bio | 1.7萬 | -4877 (-22.3%) | 需聯絡報價 | 荷蘭 | 4.5 | 比較 |
| 8 | 0xmd | 0xmd.com | 12.83萬 | -2857 (-2.2%) | 免費增值 | 中國香港特別行政區 | 4.1 | 比較 |
| 9 | Consensus | consensus.app | 601.44萬 | -7.14萬 (-1.2%) | 免費增值 | 美國 | 4.7 | 比較 |
| 10 | evidencepartners.com | evidencepartners.com | 8776 | -6671 (-43.2%) | 付費、需聯絡報價 | 加拿大 | 4.5 | 比較 |
| 11 | Connected Papers | connectedpapers.com | 75.06萬 | 2.24萬 (+3.1%) | 免費增值 | 美國 | 4.7 | 比較 |
| 12 | BioBrain Insights | biobrain.io | 2.77萬 | 6775 (+32.4%) | 需聯絡報價 | 美國 | 4.1 | 比較 |
面向臨床藥物開發的 AI 成功率分析平台

Semantic Scholar is a free, non-commercial academic search engine built by the Allen Institute for AI (Ai2). It indexes more than 240 million papers from every field of science and uses machine learning to extract meaning from abstracts, citations, figures and tables, so researchers find relevant work faster than with keyword-only search.
Semantic Scholar is a free, non-commercial academic search engine built by the Allen Institute for AI (Ai2). It indexes more than 240 million papers from every field of science and uses machine learning to extract meaning from abstracts, citations, figures and tables, so researchers find relevant work faster than with keyword-only search.

Unlearn.AI builds AI-generated digital twins of clinical trial participants — forecasts of how each individual patient's outcomes would evolve — and uses them to sharpen design, interim, and readout decisions in drug development.
Unlearn.AI builds AI-generated digital twins of clinical trial participants — forecasts of how each individual patient's outcomes would evolve — and uses them to sharpen design, interim, and readout decisions in drug development.
用視覺化論文圖譜探索學術文獻
以 AI、自動化與資料品質控管統合市場調查的敏捷 MROps 平台